Stock Comparison

ONC vs REGN

BeiGene, Ltd. and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ONC

BeiGene, Ltd.

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$39.07B

$80.55B

P/E (TTM)

61.6

19.4

Forward P/E

51.1

17.1

Price/Sales

6.4

5.2

Price/Book

7.6

2.5

EV/EBITDA

32.6

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

8.94%

29.65%

Operating Margin

11.95%

24.32%

Return on Equity

14.70%

14.00%

Return on Assets

7.46%

6.53%

Growth (YoY)

Revenue Growth

29.60%

16.70%

Earnings Growth

166.70%

-4.50%

Price & Risk

Beta

0.5

0.2

52-Week High

$377.47

$810.12

52-Week Low

$260.27

$553.38

Analyst Target

$431.34

$833.54

Compare ONC and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.